Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A leading AI-focused ETF is spreading risk across 86 stocks and delivering outsized gains, challenging the dominance ...
Traders seek faster funding, clearer terms and better payouts in 2026. This report analyzes the best prop trading fir...
February data show a modest uptick in existing-home sales, but the market faces spring headwinds from affordability p...
Oil hits $106 per barrel as Hormuz remains a flashpoint. The U.S. and NATO politics add to volatility while investors...
Trump crypto price test unfolds as the token hovers near key support while volume sinks, signaling uncertain convicti...
Binance unveils a fresh look at how digital assets widen financial inclusion in emerging markets, moving crypto from ...
Bitcoin failed to break above the 200-day moving average near $82,400 as traders weigh a pattern that CryptoQuant say...
A hidden AI stock is drawing quiet attention. This article breaks down why investors are eyeing it before its next ea...
Investors are eyeing a nuclear-powered future, but is Nuscale Power really the smartest investment today? This guide ...
May's CPI rose 0.5%, lifting inflation to 4.2% and signaling the first 4% reading in years. Energy led the gains, whi...
A shortened trading week features June triple witching and SpaceX contract launches, setting the stage for heightened...